The present invention discloses pharmaceutical compositions for preventing, improving or treating hepatic fibrosis, hepatocellular degeneration or cirrhosis, which contain a meglitinide compound such as nateglinide.

 
Web www.patentalert.com

< Associations of polymorphisms in the fibroblast growth factor 8 (FGF8) and its haplotypes with carcass quality, growth and feed efficiency in beef cattle

> Implantable Medical Electrical Stimulation Lead Fixation Method and Apparatus
~ 00497